| Literature DB >> 30687646 |
Patricia Del Portillo1, Lázaro García-Morales2, María Carmen Menéndez3, Juan Manuel Anzola1, Juan Germán Rodríguez1, Addy Cecilia Helguera-Repetto4, Miguel A Ares5, Rafael Prados-Rosales3,6, Jorge A Gonzalez-Y-Merchand7, María Jesús García3.
Abstract
The capacity of Mycobacterium tuberculosis (Mtb) to sense, respond and adapt to a variable and hostile environment within the host makes it one of the most successful human pathogens. During different stages of infection, Mtb is surrounded by a plethora of lipid molecules and current evidence points out the relevance of fatty acids during the infectious process. In this study, we have compared the transcriptional response of Mtb to hypoxia in cultures supplemented with a mix of even long-chain fatty acids or dextrose as main carbon sources. Using RNA sequencing, we have identified differential expressed genes in early and late hypoxia, defined according to the in vitro Wayne and Hayes model, and compared the results with the exponential phase of growth in both carbon sources. We show that the number of genes over-expressed in the lipid medium was quite low in both, early and late hypoxia, relative to conditions including dextrose, with the exception of transcripts of stable and non-coding RNAs, which were more expressed in the fatty acid medium. We found that sigB and sigE were over-expressed in the early phase of hypoxia, confirming their pivotal role in early adaptation to low oxygen concentration independently of the carbon source. A drastic contrast was found with the transcriptional regulatory factors at early hypoxia. Only 2 transcriptional factors were over-expressed in early hypoxia in the lipid medium compared to 37 that were over-expressed in the dextrose medium. Instead of Rv0081, known to be the central regulator of hypoxia in dextrose, Rv2745c (ClgR), seems to play a main role in hypoxia in the fatty acid medium. The low level of genes associated to the stress-response during their adaptation to hypoxia in fatty acids, suggests that this lipid environment makes hypoxia a less stressful condition for the tubercle bacilli. Taken all together, these results indicate that the presence of lipid molecules shapes the metabolic response of Mtb to an adaptive state for different stresses within the host, including hypoxia. This fact could explain the success of Mtb to establish long-term survival during latent infection.Entities:
Keywords: Mycobacterium tuberculosis; RNA-sequencing; dormancy; gene expression; hypoxia; lipid environment; stress response
Mesh:
Substances:
Year: 2019 PMID: 30687646 PMCID: PMC6333855 DOI: 10.3389/fcimb.2018.00449
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
M. tuberculosis hypoxic transcriptomes in the presence of dextrose and LC-FA.
| All | 13.12 | 14.46 | 13.88 | 18.31 | 15.74 | 10.34 |
| All mapped | 8.17 | 8.11 | 9.35 | 9.56 | 11.19 | 4.78 |
| Mapped to CDS | 0.52 (71.3) | 0.38 (48) | 0.62 (36) | 0.28 (61.6) | 0.35 (36) | 0.15 (15) |
| Mapped to IGRs | 0.17 (22.4) | 0.40 (50) | 0.87 (50.5) | 0.15 (32.9) | 0.6 (60) | 0.7 (82) |
| Mapped to antisense CDS | 0.05 (6.4) | 0.05 (5.0) | 0.02 (6.7) | 0.02 (5.4) | 0.04 (4.4) | 0.001 (1) |
Total numbers (in millions) of reads determined under the different conditions (upper part); and numbers (percentages) of reads determined by excluding those corresponding to rRNA (lower part) are shown. Data from DE and FE conditions are taken from a previous study (Rodríguez et al., .
Figure 1Venn diagram showing the number of statistically significant expressed genes by Mtb grown in conditions including early hypoxia in the presence of dextrose (DNRP1) and long-chain fatty acids (FNRP1); Endurance (EHR) regulon (Rustad et al., 2008), dosR regulon (Voskuil et al., 2004) and persister cells in antibiotics (Keren et al., 2011).
Figure 2Volcano plots showing the functional categories of genes differentially expressed during the adaptation to hypoxia under different carbon sources. (A) Hypoxia in dextrose as carbon source. Left panel, DE compared to DNRP1; right panel, DNRP1 compared to DNRP2. (B) Hypoxia in LC-FA as carbon source. Left panel, FE compared to FNRP1; right panel, FNRP1 compared to FNRP2.
Figure 3The hub of hypoxia in dextrose. The network represents genes over-expressed in DNRP1 vs. DE that interact with these TF according to the Minch's data (2015). The size of the circles is related with the number of genes controlled by the respective TF.
Figure 4Over-expressed TF identified in FNRP1 vs. FE. Genes over-expressed in the FNRP1 vs. FE that interact with Rv3765c, according to the Minch's data (2015). Because, Minch and co-workers did not identified genes controlled by the TF Rv2745, the figure showed those described in the literature (Estorninho et al., 2010; McGillivray et al., 2014).
Expression of sigma factors in the LC-FA model of hypoxia.
| DNRP1 > DE | 404 | 105 | 1.67E-69 | 3.85 | |
| 133 | 41 | 4.37E-20 | 3.24 | ||
| 14 | 5 | 0.025 | 2.80 | ||
| 315 | 43 | 7.12E-76 | 7.33 | ||
| FNRP1 > FE | 47 | 8 | 5.00E-05 | 5.88 | |
| 103 | 43 | 1.47E-03 | 2.40 |
DE, Dextrose exponential; DNRP1, Dextrose early hypoxia; FE, LC-FA exponential; FNRP1, LC-FA early hypoxia.
Figure 5Venn diagram showing the small RNAs with significant high expression during the adaptation of Mtb to hypoxia in Dextrose (DNRP2>DNRP1>DE, blue letters) and in LC-FA (FNRP2>FNRP1>FE, red letters). The enclosed table contains the new annotation for the sRNAs (Lamichhane et al., 2013). The shadowed boxes indicate those sRNAs shared between carbon sources. (A) Dextrose (DNRP2 > DNRP1 > DE, blue letters) and in (B) LC-FA (FNRP2 > FNRP1 > FE, red letters).
Expression of genes coding for toxin-antitoxin systems in the LC-FA model of hypoxia.
| DNRP1 > DE | |||||
| Rv0837c toxin | 11 | 1 | 0.003 | 11 | |
| Maz F5 toxin | 13 | 2 | 0.005 | 6.5 | |
| Vap C37 toxin | 13 | 4 | 0.03 | 3.25 | |
| Vap B10 antitoxin | 38 | 15 | 1.08E-04 | 2.53 | |
| Par E1 toxin | 21 | 9 | 0.0169 | 2.33 | |
| Par D1 antitoxin | 44 | 16 | 8.72E-06 | 2.75 | |
| Hig B2 toxin | 48 | 16 | 1.02E-06 | 3 | |
| Hig A2 antitoxin | 36 | 16 | 5.93E-04 | 2.25 | |
| TAC Hig B1 toxin | 29 | 2 | 2.47E-08 | 14.5 | |
| TAC Hig A1 antitoxin | 34 | 8 | 3.98E-06 | 4.25 | |
| TAC chaperone | 12 | 1 | 0.002 | 12 | |
| Rv2034 toxin | 21 | 7 | 0.003 | 3 | |
| Rv2035 antitoxin | 61 | 6 | 6.13E-16 | 10.17 | |
| DNRP2 > DE | Vap C20 toxin | 19 | 4 | 1.41E-15 | 4.75 |
| DNRP2 > DNRP1 | Vap C20 toxin | 19 | 6 | 6.11E-10 | 3.17 |
| FNRP1 > FE | Rv3188 toxin | 20 | 4 | 0.041 | 5 |
| FNRP2 > FNRP1 | Rv0837c toxin | 4 | 0 | 0.037 | 4 |
DE, dextrose exponential; DNRP1, dextrose early hypoxia; DNRP2, dextrose late hypoxia; FE, LC-FA exponential; FNRP1, LC-FA early hypoxia; FNRP2, LC-FA late hypoxia.
Hypoxia signature genes in dextrose and LC-FA.
| Rv0079 | 1.76E-05 | 3.26E-39 | Dormancy associated translation inhibition | |||
| Rv0103 | 6.11E-08 | 6.49E-03 | Cation-transporter P-type ATPase B | |||
| Rv0122 | 5.72E-04 | 1.90E-07 | Hypothetical protein | |||
| Rv0188 | 5.33E-14 | 7.53E-04 | Transmembrane protein | |||
| Rv0251c | 9.24E-232 | 1.19E-04 | Heat shock protein hsp | |||
| Rv0275c | 2.82E-04 | 5.52E-10 | TetR family transcriptional regulator | |||
| Rv0350 | 1.62E-68 | 3.10E-02 | Molecular chaperone DnaK | |||
| Rv0628c | 3.30E-02 | 1.16E-23 | Hypothetical protein | |||
| Rv0678 | 6.76E-13 | 5.11E-09 | Hypothetical protein | |||
| Rv0754 | 4.64E-08 | 3.30E-04 | PE-PGRS family protein | |||
| Rv0791c | 2.00E-23 | 3.86E-05 | Hypothetical protein | |||
| Rv0792c | 2.50E-58 | 2.54E-09 | GntR family transcriptional regulator | |||
| Rv0826 | 2.46E-11 | 1.80E-02 | Hypothetical protein | |||
| Rv0837c | 3.00E-03 | 2.10E-02 | Hypothetical protein | |||
| Rv0968 | 8.21E-108 | 3.21E-54 | Hypothetical protein | |||
| Rv0969 | 3.76E-57 | 1.25E-54 | Metal cation transporter P-type ATPase CtpV | |||
| Rv0983 | 1.14E-52 | 5.38E-03 | Serine protease PepD | |||
| Rv0991c | 4.59E-79 | 6.40E-04 | Serine-rich protein | |||
| Rv1221 | 7.12E-76 | 5.00E-05 | RNA polymerase sigma factor | |||
| Rv1224 | 6.27E-17 | 3.37E-45 | Sec-independent translocase | |||
| R1460 | 1.63E-05 | 8.00E-03 | Transcriptional regulatory protein | |||
| Rv1462 | 2.49E-30 | 6.42E-07 | Hypothetical protein | |||
| Rv1535 | 4.06E-05 | 4.17E-05 | Hypothetical protein | |||
| Rv1801 | 8.55E-05 | 7.07E-08 | PPE family protein | |||
| Rv1806 | 2.03E-09 | 3.01E-17 | PPE family protein | |||
| Rv1807 | 1.19E-18 | 3.40E-25 | 2.66E-04 | PPE family protein | ||
| Rv1831 | 1.76E-04 | 2.89E-262 | 1.17E-03 | Hypothetical protein | ||
| Rv1985c | 2.04E-08 | 2.88E-11 | LysR-family | |||
| Rv2050 | 1.23E-67 | 3.71E-03 | Hypothetical protein | |||
| Rv2169c | 2.07E-04 | 1.43E-03 | Transmembrane protein | |||
| Rv2516c | 4.00E-20 | 1.90E-02 | Hypothetical protein | |||
| Rv2554c | 2.14E-78 | 1.58E-09 | Holliday junction resolvase-like protein | |||
| Rv2555c | 7.94E-04 | 2.53E-253 | Alanyl-tRNA synthetase | |||
| Rv2623 | 7.38E-158 | 6.77E-67 | Hypothetical protein | |||
| Rv2694c | 7.50E-88 | 9.61E-06 | Hypothetical protein | |||
| Rv2699c | 1.20E-146 | 2.58E-05 | Hypothetical protein | |||
| Rv2710 | 1.67E-69 | 1.47E-03 | RNA polymerase sigma factor SigB | |||
| Rv2744c | 1.56E-110 | 5.42E-03 | Hypothetical protein | |||
| Rv2745c | 2.48E-297 | 9.51E-03 | Transcriptional regulatory protein | |||
| Rv3205c | 1.03E-05 | 8.37E-54 | Hypothetical protein | |||
| Rv3270 | 2.67E-22 | 2.16E-04 | Metal cation-transporting P-type ATPase C CtpC | |||
| Rv3289c | 2.30E-90 | 1.07E-22 | Transmembrane protein | |||
| Rv3290c | 5.21E-76 | 1.59E-34 | L-lysine aminotransferase | |||
| Rv3417c | 1.13E-15 | 2.66E-05 | Molecular chaperone GroEL | |||
| Rv3418c | 4.60E-13 | 2.36E-57 | Co-chaperonin GroES | |||
| Rv3461c | 5.00E-03 | 8.32E-04 | 50S ribosomal protein L36 | |||
| Rv3679 | 1.13E-11 | 2.38E-10 | Anion transporter ATPase | |||
| Rv3872 | 2.50E-05 | 4.88E-07 | PE family-like protein | |||
DE, dextrose exponential; DNRP1, dextrose early hypoxia; DNRP2, dextrose late hypoxia; FE, LC-FA exponential; FNRP1, LC-FA early hypoxia; FNRP2, LC-FA late hypoxia.